The Mets lost another starting pitcher on Thursday, as the team announced that the pain that forced Max Scherzer from his start Wednesday has been diagnosed as a moderate to high grade oblique sprain; the anticipated timetable for Scherzer’s return is six to eight weeks. After throwing a slider to Albert Pujols, Scherzer was in visible discomfort and quickly pulled the plug himself, sparing Buck Showalter the most dangerous part of a manager’s job: telling Max Scherzer to hit the showers:

The loss of Scherzer comes at a time the Mets are already down two other starting pitchers (three if you count Joey Lucchesi‘s loss to Tommy John surgery, which I’m not). Most notably, Jacob deGrom’s 2022 season has yet to begin due to a stress reaction in his right scapula. Tylor Megill is also currently on the IL due to biceps tendinitis diagnosed after the worst start of his professional career. Luckily, there’s reason to be hopeful in both cases. The most recent imaging of deGrom’s scapula indicated it is healing effectively, raising hopes that the ace’s return isn’t too far off. Meanwhile, Megill’s MRI didn’t reveal anything darker than a case of tendinitis, and he’s already scheduled to play catch today:

Jacob deGrom's MRI and CT scan revealed "considerable healing of the stress reaction on his scapula," Mets say.

He has been cleared to begin loading and strengthening his shoulder and will be "re-imaged in approximately three weeks."

— Deesha (@DeeshaThosar) April 26, 2022

Read the rest of this entry »

12:00

Dan Szymborski: And we are here as this is a chat!

12:02

Dan Szymborski: The dead ball helps him a bit. His cutter’s generally been working, and his peripheral numbers have improved too. He’s had runs where his cutter’s been working and he’s been effective, but he has had trouble keeping that up

12:03

Dan Szymborski: Yeah, in fact, he has better advanced hitting stats better than most guys playing that poorly

Read the rest of this entry »

The main reason why the Astros have been able to survive and thrive despite the departure of a large percentage of the core of their 2017 World Series-winning team is their success in developing their young talent. One of the most prominent of these players, Kyle Tucker, had his breakout season in the shortened 2020 and cemented those gains with a .294/.359/.557, 4.9 WAR 2021 campaign that saw him get his first MVP votes. With Tucker heading to arbitration this winter for the first time, the Astros discussed a long-term contract with their incumbent right fielder in recent weeks, but the deal has apparently fallen through.

The Astros recently spoke with Kyle Tucker’s camp about a contract extension, but the sides were unable to come to a deal and are no longer engaged, sources tell me and @brianmctaggart. Tucker will become arbitration-eligible for the first time at the end of this season.

— Mark Feinsand (@Feinsand) May 16, 2022

While it hasn’t worked out, it’s the right idea. Teams want to lock up their best young players, and many players, especially before they get that first big arbitration bump, are interested in mitigating their personal risk. Wander Franco was more likely than not to beat the $182 million he’ll receive from the Rays and the team they trade him to around 2029, but it also provided him some real security, given he’s still a couple years from arbitration. These types of deals can be win-win.

So who should be the next players to get inked for the long haul? Here are my favorite picks. For each, I’ve included their ZiPS projections for both performance and a fair contract; after all, I don’t own a team, so I don’t have the motivation to pitch any absurdly team-friendly agreements like the one Ozzie Albies signed with the Braves. I’ve also omitted Juan Soto since we’ve already talked about him and a long-term deal quite a bit, most recently in Jay Jaffe’s piece before the season that already has the ZiPS projections. If you want a figure, let’s just say 10 years and all circulating US currency. Read the rest of this entry »

Pitchers getting injured is never good news, even in a year in which pitching talent seems relatively easy to come by. Sadly, we got a bunch of high-profile names hitting the IL over the weekend, so here’s a quick Monday rundown in case you were doing something more fun on Sunday than stressing about injuries, like watching the baseball games (non-Giants fans, at least).

Tylor Megill, New York Mets

Given the monumental task of replacing Jacob deGrom in the Mets’ rotation at the start of the season, Megill took his job surprisingly literally, doing his best imitation of the team’s ace. Through six starts, his ERA stood at 2.43 with a nearly identical FIP at 2.44, improving significantly on his major league debut in 2021. Then came the worst start of his professional career — including the minors — as he surrendered eight runs and didn’t even make it through the second inning against the Nationals last Wednesday. Megill can’t point to bad luck either; it’s hard to complain too strenuously about BABIP when you have an xBA of .563 and an xSLG of 1.263.

On the plus side, Megill’s velocity wasn’t down during that disaster of a start, and he didn’t report any discomfort until after the game. One thing that struck me, however, is how much his horizontal release point has changed in a lateral direction throughout the season. From his first start to his last outing, Megill’s horizontal release point has shifted about five inches; those release points tend to be far more consistent in-season, as players are more likely to tinker with this in the winter and spring. Release point inconsistency is a concern, and at least one study that I’m familiar with has linked shifting lateral release points with an eventual need for Tommy John surgery, albeit with low odds (a roughly 5% higher chance of a UCL tear with every 10 centimeters of movement). That’s getting ahead of ourselves, but it’s something to file in the back of your mind.

The decision to put Megill on the IL was made after he experienced soreness during his bullpen on Saturday, with biceps tendinitis as the announced culprit. Colin Holderman got the immediate call-up to take Megill’s spot on the roster, though that may be short-lived, as David Peterson started on Friday. Trevor Williams will get Megill’s start on Monday night against the Cardinals.

In other Mets injury news — of course there’s more, it’s the Mets — catcher James McCann will be out six weeks due to a broken hamate bone. Patrick Mazeika was called up and likely endeared himself to Mets fans more than McCann has by hitting the go-ahead home run in the seventh on Saturday against the Mariners. McCann’s offense has disappeared so quickly over the last year-plus that there’s not likely to be any real consequence for the Mets other than a thinning of the depth chart.

Jesús Luzardo, Miami Marlins

Amid a promising comeback campaign, Luzardo took a step back last week, walking four and allowing four runs in 2.2 innings against the Diamondbacks, bloating his ERA to 4.03. Like Megill, there were no suspicious velocity dropoffs — something to watch for given Luzardo’s injury history — but he reported forearm soreness after the game. In “crossing our fingers” news, he did not believe the pain was similar to what he experienced before his first Tommy John surgery, back when he was a high schooler in 2016:

What Jesús Luzardo had to say about his left forearm strain. #Marlins pic.twitter.com/YAhoKsAXuv

— Christina De Nicola (@CDeNicola13) May 15, 2022

I just started feeling a little something in the San Diego game, towards the back end of it, but nothing when I was pitching or anything like that. It was more just a little soreness. I kind of backed off a little between my starts. There wasn’t really pain or anything, more like stiffness.

The Marlins held off until this weekend to place Luzardo on the IL, retroactive to his May 10 start, when it became evident that he would be unavailable. It seems that Cody Poteet, already stretched out a bit in relief of Luzardo against Arizona and not used since, will get the spot start on Tuesday, with Sandy Alcantara going on Monday.

As for replacing Luzardo long-term, it doesn’t appear as if the Marlins plan to recall top prospect Max Meyer to fill the spot. My reading of the tea leaves is that they’re not going to push Edward Cabrera up soon as a replacement either; while he’ll get another chance in the not-too-distant future, I think Saturday’s start against Triple-A Nashville would have been a few tune-up innings rather than a 90-pitch outing if a callup was imminent.

Short of any additional bad news, it’s entirely possible that, with two off days in the next week, Luzardo may only miss just the one start.

Clayton Kershaw, Los Angeles Dodgers

Kershaw was a late scratch on Friday against the Phillies, pushing Walker Buehler’s start up a day on normal rest. Kershaw has a history of lower back pain and at least one instance (2012) of hip impingement, so the Dodgers are being careful with him. The culprit this time is inflammation of the SI joint, which, I believe, is the sacroiliac joint and not the Sports Illustrated joint; on the pelvis, it’s between the hip and the spine. As I did not attend Hollywood Upstairs Medical College, and my medical knowledge is primarily evaluating how sick I’ll feel if I eat some deliciously spicy food, let’s consult actual doctors here:

Biomechanically, the sacroiliac joint performs several functions. Primarily, its purpose is to attenuate the distribution of force loads from the lower extremities. It functions both as a shock absorber for the spine above and converts torque from the lower extremities into the rest of the body.

As pitching largely involves transfers of force between body parts, it’s understandable why the Dodgers see the need to be cautious. Last year was the first time Kershaw was placed on the IL with elbow issues, and given that it scared them enough to shut him down quickly for the postseason, this is not unexpected caution.

To replace Kershaw on the roster, the Dodgers called up Michael Grove, who got the start on Sunday and may get another down the road, though with a very quick hook. Andre Jackson looked like a rotation fallback option at the start of the season, but he’s failed to finish the third in each of his last three starts for Triple-A Oklahoma City, allowing 10 walks in just 3.1 innings.

If there’s anything as inevitable as the Tampa Bay Rays trading away a top starting pitcher, typically for salary reasons, it’s their development of the next one. Shane McClanahan looks a lot like their next one. The Baltimore native was highly effective in his rookie season, putting up a 3.34 ERA and 3.31 FIP with 10 strikeouts per nine over 25 starts in 2021. Even more impressive, he did it with minimal professional experience, with only four games in the high minors before becoming the first pitcher to make his major league debut in a playoff game.

2021 was a fine rookie season for McClanahan, but 2022 is looking like something special. In seven starts, his ERA stands at 2.52, and with a FIP of 2.67, it’s not a BABIP-fueled mirage. His strikeout percentage has jumped by about 40% year-on-year, from 27% to 38%, a notable improvement even in a very pitcher-friendly season. Batters are making both less contact than last year (dipping from 70.4% to 63.6%) and worse contact — their average exit velocity declined from 91.7 mph to 89.3, while their Statcast sweet spot percentage dipped from 36.8% to 26.5%. Among all pitchers with at least 20 innings thrown this season, only Corbin Burnes and Michael King have lower contact rates.

One of the primary differences between this season and last season for McClanahan has been the development of his changeup. Despite a fastball that can hit the high-90s with some nasty late break, McClanahan does not use his heat to finish off batters the way pitchers like Brandon Woodruff or Lance Lynn tend to. In fact, when batters get to him, it’s usually on the fastball, with a batting average well over .300 and 12 of his 19 career home runs allowed coming on the heater. Read the rest of this entry »

12:02

Dan Szymborski: Good afternoon!

12:03

Dan Szymborski:

12:03

Dan Szymborski: I’m still on slow start.

12:04

Dan Szymborski: Depends. I’m not a coder, I’m a math guy who codes a little when he’s stuck doing. I use a combination of Excel with some statistical package third party add-ons and Visual Basic

Read the rest of this entry »

Every year, Byron Buxton seems to find another gear. With the exception of his abbreviated 2018 (94 plate appearances in the majors), Buxton’s OPS has increased every single season compared to the year before. In 2022, partly thanks to becoming a fastball-crushing machine since the start of last year, he’s continued this pattern, hitting .278/.342/.722 in 79 plate appearances (all stats are through Monday’s action). He’s even tied for the league lead in home runs with nine, especially impressive given that he’s missed more than a third of Minnesota’s games.

It’s that last fact that is troubling, as Buxton’s career has been hampered by an unfortunate inability to stay healthy. And it hasn’t been one, consistent problem that keeps him out of games but rather a succession of nagging ones, with each season bringing a mystery grab bag of misfortune. This year, it’s been a sore knee from a slide, a hand contusion, and a hip problem. Last year, it was a hip, a hamstring, and a broken hand. Before 2021, he missed time due to a concussion, a sore left shoulder, a sprained left foot, a torn labrum, another concussion, a hit by a pitch to the wrist, a different strain to the same wrist, a broken toe, serious migraines after an outfield wall collision, a strained groin, and a sprained knee — and that doesn’t count the myriad day-to-day issues.

The last time Buxton played even 100 games in a season was in 2017 (while there were only 60 games in 2020, he still missed a third of them). I was born in 1978; growing up, Eric Davis was the five-tool, mega-skilled exemplar of the dynamic superstar who couldn’t stay healthy, but even he still managed to get into 130 games a year during his 1986–90 peak. Buxton debuted almost seven years ago, in June 2015, and barely has three years’ worth of playing time in the majors to go along with another half-season in the minors due to Minnesota’s early proclivity for demoting him every time he fell into a slump. Read the rest of this entry »

On May 1, the Twins beat the Rays while the White Sox saw a late-inning comeback attempt against the Angels foiled. There was nothing particularly newsworthy about these games, but they did have a significant impact in the ZiPS projections: for the first time since early 2021, the White Sox were no longer the favorite to win the division.

Before the season started, ZiPS saw the AL Central as Chicago’s to lose, a calculation that was not going against the conventional wisdom. With a 61.9% projected chance of winning the division, ZiPS had the White Sox with the second-best divisional crown probability of any team in baseball on Opening Day, just below the Astros and their 62.8% chance of winning the AL West. And that projection had been even sunnier a month prior. When the lockout ended and we started Hot Stove League II: The Legend of Manfred’s Gold, ZiPS gave the White Sox a 10-game lead in the division and a 70.7% chance of finishing first in the Central. The team ZiPS was most worried about, from the point of view of the Pale Hose, wasn’t the Twins, but the Guardians, a team that didn’t even project to reach the .500 mark.

Amid the flurry of moves leading up to the lockout, Minnesota was very quiet, with Dylan Bundy as the club’s “big” signing. But once the lockout lifted, the Twins got into gear, picking up Sonny Gray, Gio Urshela, Gary Sánchez, Chris Paddack, Emilio Pagán, and Isiah Kiner-Falefa and trading away Josh Donaldson, Taylor Rogers, various prospects, and… Isiah Kiner-Falefa. The Twins also shocked the baseball world by getting Carlos Correa, one of the winter’s prime free agents, to sign a three-year contract worth $105.3 million, with opt-outs.

By the time all the roster shakeups and offseason moves finished, ZiPS had Minnesota’s 13-win shortfall against the White Sox down to just five wins. That’s a respectable cushion, but not one that will provide padding for all butts in all situations. And as I noted above, said cushion was all but gone by the beginning of May, though after two losses by the Twins and a win (and an off-day) for the White Sox, Chicago has narrowly taken back the lead in the projections:

Chicago is the very slight favorite right now, but that can hardly be taken as a victory considering it represents basically a quarter-of-a-division crown that has evaporated in the last two months.

Some, but not all of the differences can be attributed to injury. Yoán Moncada was injured the day I ran the projections, though it didn’t look significant at that point. Eloy Jiménez is out as well, likely for a couple of months at least, and Lance Lynn is yet to make a start. Andrew Vaughn, one of the team’s few offensive bright spots, is also out with a bruised hand, though that looks far less serious than Jiménez’s hamstring.

But the Twins have their own recent injuries as well, in Gray, Bailey Ober, Jhon Romero, Miguel Sanó, and now Correa, who left Thursday’s game with a potentially fractured finger on his right hand. You always expect some injuries in the course of play; everyone being healthy isn’t the baseline expectation for anyone being realistic. The White Sox have good pitching depth that’s helped them survive Lynn’s absence and a brief IL stint by Lucas Giolito, but some of the offensive struggles (13th in the AL in runs scored) have to be chalked up to poor planning by the organization, and that’s not something you can attribute to poor luck.

Entering the season with a major hole at second base was a choice, not something fate thrust upon them. I thought at the time of the Craig Kimbrel trade that giving up Nick Madrigal was reasonable, something that many of you disagreed with at the time (and so far, it’s looking like I’m the loser in that debate). But my feelings about that trade would have been very different if you told me in advance that the White Sox were basically going to shout “Pass!” when it came to finding a replacement and would roll with a Leury García/Josh Harrison combination. No team we projected with a winning record had a worse depth chart projection at second entering the season.

Similarly, in right field, our preseason depth charts had the Sox above only two other squads projected to finish above .500. Picking up AJ Pollock was a good development, but the rest of the outfield consisted of two young players who missed a lot of time in 2021 with serious injuries (Jiménez and Luis Robert), Pollock has a lengthy injury history himself, and Vaughn was still a bit of a question mark. It only took a few injuries to stretch the team’s depth in both the infield and outfield.

Baseball’s new playoff system should have the White Sox determined to do more than coast to the divisional crown; with the weakest division winner put into a short wild-card round, ZiPS projected them as being the biggest loser in a 12-team playoff format. The good news is that, despite the problems so far, ZiPS sees Chicago’s decline in rest-of-season roster strength as a small one, from .531 to .527 before the strength of schedule is taken into consideration; the Twins have only improved from .508 to .509. The problem is that the good news is also bad news: ZiPS thinks that the relative strengths of the two teams aren’t drastically different than a month ago and still sees the division as a coin flip. To get the White Sox a comfortable division lead, you now have to think the White Sox are considerably better than their preseason projection.

In short, the White Sox need to be better than they are now to regain the projected ground they lost. Even with a second wild card, that’s not necessarily a simple fallback position; ZiPS sees the average second AL wild card being an 89-win team and the average AL Central victor an 88-win team. What this means is that the Sox ought to be incentivized to be aggressive rather than reactive. Robinson Canó may be toast, but the chance that he isn’t is certainly worth the risk of a minimum salary. Don’t wait for another team to acquire Ramón Laureano in July before making an underwhelming counter-move; be the team that snags him in the first place, as quickly as possible. Get away from the idea that the contributions from any position are “enough” and adopt the mindset of brutally grabbing any opportunity that arises in the coming months. That’s what the Dodgers do.

The White Sox didn’t expect to be in a tight divisional race in 2022. They are now, and it’s time for them to act like it.

12:01

Dan Szymborski: Happy Cinco de Mayo! I hope you’re all recovered from Cinco de Cuatro.

12:01

Dan Szymborski: Heh. Nothing, I’ve got a stomach ache.

12:02

Dan Szymborski: A lot of their highlights are likely going to be Suzuki related!

12:02

Dan Szymborski: Plus, not being the Reds is very nice.

Read the rest of this entry »

Forced to squeeze their roster down to a 26-man limit on Monday, the Mets decided to say goodbye to veteran second baseman Robinson Canó, designating him and the two years left on his contract for assignment. Canó, who will turn 40 this year, struggled greatly in 12 games in 2021, going 8-for-41 with just a single extra-base hit, a solo homer off of Zach Davies. While he could theoretically be claimed on waivers before being released, any team adding him by this route would commit to the $40 million still owed him through 2023, which is, let’s just say, unlikely to happen.

The decisions both to play Canó and to cut him this year were surprisingly easy. He did play very well the last time we saw him, in the COVID-shortened 2020 season, hitting .316/.352/.544 with 10 homers for a 142 wRC+ and 1.3 WAR in just 49 games. The problem is that the last time we saw him was 2020 thanks to a PED suspension that November, his second positive steroid test under MLB’s drug-testing regimen and one that cost him the entire ’21 campaign.

I wasn’t really worried about the suspension itself; I’ve spent the last decade trying to find some kind of discernible pattern, short- or long-term, of over- or under-performance for the group of players busted for PED use and have yet to find anything actually useful. But what did worry me was the missed time coming on the back of an artificially short season for a 39-year-old player playing a premium defensive position. While Canó was quite good in 2020, his 2019 season was by far his worst season in a long time.

While I think it made perfect sense for the Mets to open the season with Canó and see what he had left, there was no particular reason for them to give him a very long leash. Jeff McNeil is playing well, and the team should roll with him starting most games at second. And with the need to cut the roster from 28 to 26 players, who would have been a better idea to cut? Luis Guillorme has been a rock-solid role player during the last few years, and even if he were struggling, he’s the backup shortstop. Dominic Smith hasn’t had a great start, but he’s contributed more than Canó has. Optioning Tylor Megill or Drew Smith would have have been completely absurd.

Mets owner Steve Cohen certainly ought to know a sunk cost when he sees one, and there’s no psychological need to salvage the Canó trade, as it was something this régime inherited from the Wilpons and former general manager Brodie Van Wagenen, not a transaction that they masterminded. The Mets expect to contend this year and are in first place by three games, so this is a team that ought to be more interested in certainty rather than chasing the chance that Canó turns things around.

Is Canó done? I wouldn’t necessarily shovel that last bit of dirt onto his career quite that quickly. Neither ZiPS (.254/.298/.393) nor Steamer (.249/.298/.385) are all that optimistic, but the margin of error here is absolutely huge. For a team that’s actually desperate at second base or a lousy one that can afford to absorb such a risky player, there’s still an argument for Canó as an addition to the roster. It wouldn’t be preposterous for the White Sox, for example, to take a look given that the combination of Leury García and Josh Harrison has been positively dreadful at second.

Whether or not Canó bounces back to close out his 10-year, $216 million contract, there’s no denying that his career is coming to an end. And overall, it’s a sad one, particularly given the friendly rivalry between Canó and another of the great second basemen of that era: Dustin Pedroia. Which player was the better second baseman was a hotly debated topic a decade ago and a fun part of the usual Red Sox-Yankees rivalry. While I don’t want to name any names, a couple of huge fans I know on Twitter spent a long time arguing that question, frequently roping me in the conversation to settle a particular aspect of the argument.

It would have been crazy to say in 2012, but I assume now that neither will make the Hall of Fame. Knee injuries basically ended Pedroia’s career at age 33, and his counting numbers are likely too light for him to get 75% of Hall voters on his side. Canó’s numbers are closer, but he’s unlikely to reach 3,000 hits. More importantly, if the first PED suspension didn’t slam the door shut in Cooperstown, the second one certainly did. While I intend to check Canó’s box someday, I’m confident I’m in the minority.

Is Robinson Canó done? Maybe, maybe not. The Mets rightly decided that they didn’t want to be the ones who needed to find out the answer to that question.